HCA HEALTHCARE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 313.9 USD | -2.71% |
|
-4.56% | +15.96% |
| Apr. 15 | Truist Securities Adjusts Price Target on HCA Healthcare to $375 From $345 | MT |
| Apr. 15 | Ondine Biomedical's Steriwave reduces SSI's by 32%, study shows | AN |
Financials (USD)
| Sales 2024 * | 69.12B | Sales 2025 * | 72.84B | Capitalization | 85.34B |
|---|---|---|---|---|---|
| Net income 2024 * | 5.41B | Net income 2025 * | 5.86B | EV / Sales 2024 * | 1.8 x |
| Net Debt 2024 * | 39.34B | Net Debt 2025 * | 38.51B | EV / Sales 2025 * | 1.7 x |
| P/E ratio 2024 * |
15.7
x | P/E ratio 2025 * |
14.1
x | Employees | 265,000 |
| Yield 2024 * |
0.81% | Yield 2025 * |
0.87% | Free-Float | 72.78% |
More Fundamentals
* Assessed data
More news
Latest transcript on HCA Healthcare, Inc.
More recommendations
More press releases
More news
| 1 day | -2.08% | ||
| 1 week | -3.76% | ||
| Current month | -5.09% | ||
| 1 month | -3.25% | ||
| 3 months | +12.72% | ||
| 6 months | +32.21% | ||
| Current year | +16.94% |
1 week
315.32
329.93
1 month
315.32335.83
Current year
268.80335.83
1 year
215.96335.83
3 years
164.47335.83
5 years
58.38335.83
10 years
43.91335.83
| Managers | Title | Age | Since |
|---|---|---|---|
Samuel Hazen
CEO | Chief Executive Officer | 62 | 10-11-21 |
| Director of Finance/CFO | 60 | - | |
Chad Wasserman
CTO | Chief Tech/Sci/R&D Officer | - | Jan. 31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Robert Dennis
BRD | Director/Board Member | 70 | 14-01-31 |
Hugh Johnston
BRD | Director/Board Member | 62 | 21-08-31 |
| Director/Board Member | 72 | 10-12-23 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.96% | 8 M€ | -.--% | ||
| 1.88% | 18 M€ | +3.25% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-16 | 313.9 | -2.71% | 1 623 117 |
| 24-04-15 | 322.6 | -0.06% | 731,891 |
| 24-04-12 | 322.8 | -1.35% | 994,870 |
| 24-04-11 | 327.2 | -0.16% | 643,375 |
| 24-04-10 | 327.8 | -0.34% | 735,175 |
Delayed Quote Nyse, April 16, 2024 at 09:49 am EDT
More quotes
HCA Healthcare, Inc. specializes in owning and operating healthcare facilities. The group offers hospital services, ambulatory care and emergency care services, acute care services, surgical services, imaging and diagnostic services, laboratory services, etc.
At the end of 2022, the group operated 182 hospitals (including 175 general hospitals, 5 psychiatric hospitals and 2 rehabilitation hospitals) located in the United States (175) and the United Kingdom (7), as well as 126 surgery centers and 21 endoscopy centers in the United States.
Calendar
2024-04-25
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
322.6
USD
Average target price
341.2
USD
Spread / Average Target
+5.75%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +16.94% | 85.34B | |
| -11.73% | 86.92B | |
| +12.75% | 29.88B | |
| -10.84% | 17.1B | |
| -6.38% | 15.24B | |
| -6.97% | 14.29B | |
| +0.10% | 12.38B | |
| -31.58% | 12.1B | |
| +23.64% | 11.4B | |
| +6.65% | 11.21B |
- Stock Market
- Equities
- HCA Stock
